Variant metabolizing gene alleles determine the genotoxicity of benzo[a]pyrene

Environmental and Molecular Mutagenesis

Volumn 37, Issue 1, 2001, Pages 17-26

  Salama, Salama A ^a,b   Sierra Torres, Carlos H ^a   Young Oh, Hye ^c   Hamada, Farid A ^b   Au, William W ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b Al Azhar University   (Egypt)

^c Korea Food and Drug Administration   (South Korea)

Author keywords

Carcinogenesis; Chemical metabolism; Chromosome aberrations; Genetic susceptibility; Genetic toxicology; Polymorphic genes; Toxicology

Indexed keywords

BENZO[A]PYRENE; DNA;

ALLELE; ARTICLE; CHROMOSOME ABERRATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTOXICITY; GENOTYPE; HUMAN; HUMAN CELL; LYMPHOCYTE; SISTER CHROMATID EXCHANGE;

ADULT; ALLELES; BENZO(A)PYRENE; BIOLOGICAL MARKERS; BIOTRANSFORMATION; CHROMOSOME ABERRATIONS; EPOXIDE HYDROLASES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOCYTES; MIDDLE AGED; MUTAGENICITY TESTS; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; SISTER CHROMATID EXCHANGE;

EID: 0035141017     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2280(2001)37:1<17::AID-EM1002>3.0.CO;2-F     Document Type: Article

References (62)

1. Association of the NAT1*10 genotype with increased chromosome aberrations and higher lung cancer risk in cigarette smokers
2. Role of polymorphic CYP2E1 and CYP2D6 genes in NNK-induced chromosome aberrations in cultured human lymphocytes
3. Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients
4. Inheritance of polymorphic metabolizing genes on environmental disease and quality of life
5. Cytogenetic effects from exposure to mixed pesticides and the influence from genetic susceptibility
6. The role of individual susceptibility in cancer burden related to environmental exposure
7. Genetic risk and carcinogen exposure: A common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer
8. Association between lung cancer and microsomal epoxide hydrolase genotypes
9. Biochemical genetics of glutathione-S-transferase in man
10. Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Preliminary results of an Italian cohort study
11. New goals for the U.S. Human Genome Project: 1998-2003
12. Predisposing genes and increased chromosome aberrations in lung cancer cigarette smokers
13. A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic human cytochrome P4502D6
14. Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility
15. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: Studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers
16. Review of studies of selected metabolic polymorphisms and cancer
17. Detection of hyperdiploidy and chromosome breakage in interphase human lymphocytes following exposure to the benzene metabolite hydroquinone using multicolor fluorescence in situ hybridization with DNA probes
18. Metabolic differences between whole blood and isolated lymphocyte cultures for micronucleus (MN) induction by cyclophosphamide and benzo[a]pyrene
19. Combined genetic polymorphism and risk for development of lung cancer
20. Benzo[alpha]pyrene metabolism, activation and carcinogenesis: Role and regulation of mixed-function oxidases and related enzymes
21. Polycyclic aromatic hydrocarbon-DNA adducts in smokers and their relationship to micronutrient levels and the glutathione-S-transferase MI genotype
22. Chromosomal aberrations in lymphocytes predict human cancer: A report from the European Study Group on Cytogenetic Biomarkers and Health (ESCH)
23. Liver glutathione S-transferase polymorphism in Japanese and its pharmacogenetic importance
24. Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancer
25. Human microsomal epoxide hydrolase: Genetic polymorphism and functional expression in vitro of amino acid variants
26. Human hepatic microsomal epoxide hydrolase: Comparative analysis of polymorphic expression
27. Advantages and disadvantages of using human cells for pharmacological and toxicological studies
28. Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene
29. Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumours
30. Point-mutational MspI and IIe-Val polymorphisms closely linked in the CYP1A1 gene: Lack of association with susceptibility to lung cancer in a Finnish study population
31. The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung
32. Aromatic DNA adducts, micronuclei and genetic polymorphism for CYP1A1 and GST1 in chimney sweeps
33. Environment institute lays plans for gene hunt
34. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo
35. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma
36. Polymorphisms in the glutathione S-transferase class mu and theta genes interact and increase susceptibility to lung cancer in minority populations (Texas, United States)
37. The human glutathione S-transferase supergene family, its polymorphism, and its effects on susceptibility to lung cancer
38. Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer
39. Post-transcriptional regulation of human microsomal epoxide hydrolase
40. Lung cancer risk in relation to genetic polymorphisms of microsomal epoxide hydrolase among African-Americans and Caucasians in Los Angeles County
41. Glutathione-S-transferases pi, alpha, mu and mdr1 mRNA expression in normal lymphocytes and chronic lymphocytic leukemia
42. Allelic deletion at glutathione S-transferase M1 locus and its association with breast cancer susceptibility
43. A simple salting out procedure for extracting DNA from human nucleated cells
44. Glutathione S-transferase mu polymorphism and susceptibility to lung cancer in the Portuguese population
45. Genetic polymorphisms of importance in biomonitoring
46. Human peripheral lymphocytes as indicators of microsomal epoxide hydrolase activity in liver and lung
47. Epoxide hydrolase: Polymorphism and role in toxicology
48. Impact of inherited polymorphisms in glutathione S-transferase M1, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo(a)pyrene-diolepoxide
49. Genetic polymorphism of xenobiotic metabolizing enzymes among Chinese lung cancer patients
50. Lymphocyte microsomal epoxide hydrolase in patients on carbamazepine therapy
51. Human microsomal epoxide hydrolase: 5′-flanking region genetic polymorphisms
52. Detection of chromosomal alterations affecting the 1cen-1q12 region in irradiated granulocytes and lymphocytes by multicolour FISH with tandem DNA probes
53. Detection of hyperdiploidy and breakage affecting the 1cen-1q12 region of cultured interphase human lymphocytes treated with various genotoxic agents
54. Role of polymorphic GSTM1 and GSTT1 genotypes on NNK-induced genotoxicity
55. Genetic polymorphism of CYP2D6 and lung cancer risk
56. Pharmacogenetics: Detecting sensitive populations
57. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema
58. Effect of glutathione S-transferase M1 polymorphisms on biomarkers of exposure and effects
59. Glutathione S-transferase activity and glutathione S-transferase mu expression in subjects with risk for colorectal cancer
60. Human CYP1A1 (cytochrome P(1)450) gene: Lack of association between the Msp I restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population
61. Some experimental design and analysis considerations for cytogenetics studies
62. Cytochrome P450 CYP1A1 MspI polymorphism and lung cancer susceptibility